Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Immune Cell-Specific Genetic Regulation in Graves' Disease: An Integrative Mendelian Randomization Study.

Endocrine, metabolic & immune disorders drug targets·2026
Same author

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Research square·2026
Same author

Transferable Deep Reinforcement Learning With Edge-Contour-Depth Fusion for Autonomous Wireless Capsule Endoscopy Navigation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Children's self-regulation development: Continuity, change, and parenting daily hassles.

Journal of applied developmental psychology·2026
Same author

Venetoclax, azacitidine, and chidamide in combination with cytarabine, aclarubicin, and G-CSF as induction chemotherapy for myelodysplasia-related acute myeloid leukemia.

Clinical and experimental medicine·2026
Same author

Material Hardship Trajectories From Infancy to Adolescence: Intergenerational Impact on Emerging Adults' Educational Pathways.

Family process·2026
Same journal

Brief transdiagnostic cognitive behavioral therapy and expressive writing for hazardous drinking and posttraumatic stress symptoms among sexual and gender minority adults: Pilot trial protocol.

Contemporary clinical trials communications·2026
Same journal

Prehabilitation in lung cancer patients undergoing lung resection surgery (Fit4LungNeo): study protocol.

Contemporary clinical trials communications·2026
Same journal

Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial.

Contemporary clinical trials communications·2026
Same journal

Implementation science and the clinical trial workforce: A national needs assessment of training and practice.

Contemporary clinical trials communications·2026
Same journal

Understanding recruitment challenges in Swiss oncology trials: Patient voices from focus groups.

Contemporary clinical trials communications·2026
Same journal

Effectiveness of couple-based maternity education on husbands' involvement in maternity continuum of care service utilization in rural communities of Central Ethiopia: Protocol of cluster randomized controlled trial.

Contemporary clinical trials communications·2026
查看所有相关文章

相关实验视频

Updated: Jun 20, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

对于瘤学剂量发现剂量优化有三个步骤.

Jason J Z Liao1, Ekaterine Asatiani2, Qingyang Liu1

  • 1Incyte Corporation, 1801 Augustine Cut-off, Wilmington, DE, 19803, United States.

Contemporary clinical trials communications
|July 22, 2024
PubMed
概括
此摘要是机器生成的。

一种新的三步方法提高了瘤药物剂量选择,超出了传统的最大耐受剂量 (MTD) 方法. 这一策略优化了注册试验的剂量,平衡了针对性治疗的安全性和有效性.

关键词:
剂量检测方法 剂量检测方法剂量优化的优化分数因数设计的分数因数设计.混合式设计 混合式设计在MTD/MAD上使用.RDE RDE 的意思是什么?

更多相关视频

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

相关实验视频

Last Updated: Jun 20, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

科学领域:

  • 在瘤学瘤学.
  • 临床药理学 临床药理学
  • 药物开发 药物开发

背景情况:

  • 传统的瘤学剂量选择依赖于最大耐受剂量 (MTD),这可能不适合分子向疗法,因为不同的毒性概况.
  • 美国食品和药物管理局的项目Optimus旨在改革瘤药物开发中的剂量优化.

研究的目的:

  • 为响应 Project Optimus 项目的倡议,提出并详细说明"向剂量优化迈进的三步"程序.
  • 加强瘤学注册试验最佳剂量选择.

主要方法:

  • 步骤1:使用高效的混合设计进行剂量升级,以识别MTD或过量控制的最大给药剂量.
  • 步骤2:根据安全性,药理动力学,药理动力学和生物标志物数据选择推剂量扩张 (RDE).
  • 步骤3:使用随机分数因数设计和多个RDE在瘤队列中的剂量优化.

主要成果:

  • 拟议的混合设计提高了MTD识别的准确性.
  • 多种数据 (安全性,PK,PD,生物标志物) 的整合为RDE选择提供了信息.
  • 分数因数设计允许探索多个剂量和瘤类型,以获得最佳的注册剂量选择.

结论:

  • 三步方法增加了选择注册试验最佳剂量的可能性.
  • 这种方法旨在实现平衡的安全性,同时保持有效性.
  • 它有助于识别对研究治疗最有反应的瘤类型.